Search

Your search keyword '"Martín-Carbonero, L."' showing total 222 results

Search Constraints

Start Over You searched for: Author "Martín-Carbonero, L." Remove constraint Author: "Martín-Carbonero, L."
222 results on '"Martín-Carbonero, L."'

Search Results

1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

2. Screening for HTLV-1 infection should be expanded in Europe

3. HTLV-1-associated myelopathy in Spain

4. HTLV-1 infection among Latin American pregnant women living in Spain

5. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

6. Three‐year efficacy of switching to dolutegravir plus lamivudine: A real‐world study

7. Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD

8. Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens

11. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

17. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

20. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

23. Allogeneic stem cell transplant in individuals living with HIV-1: an update of the IciStem Consortium

25. High incidence of persistently altered liver tests after sustained virological response with direct-acting antiviral in hepatitis C monoinfected and HIV-coinfected patients

26. High sustained virological response rates in hepatitis C genotypes 1a and 4 patients treated with elbasvir and grazoprevir and basal viremia >800.000 UI/mL

27. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

28. Sustained virological response in HIV/HCV co‐infected patients without rapid virological response (RVR) on peginterferon‐ribavirin therapy

32. SAT-206 - Differences between Hepatitis HCV-Monoinfected and HCV-HIV-Coinfected Patients Treated with New Daa-Based Therapies

33. Do interleukin‐28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

34. No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

44. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.

48. Sustained virological response in HIV/HCV coinfected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy.

49. O124. Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients.

50. Hepatic steatosis-insulin resistance and type 2 diabetes in people with HIV at diagnosis: effect of initial antiretroviral therapy.

Catalog

Books, media, physical & digital resources